Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.

@article{Stocchi1999ManagementOH,
  title={Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.},
  author={Raffaella Stocchi and Katherine Nora Ward and Renato Fanin and Michele Baccarani and Jane F. Apperley},
  journal={Haematologica},
  year={1999},
  volume={84 1},
  pages={71-9}
}
BACKGROUND AND OBJECTIVE Human cytomegalovirus (HCMV) infection and disease remain a major cause of morbidity and mortality after bone marrow transplantation. HCMV disease, especially pneumonitis, may be treated with ganciclovir and immunoglobulin but even so the outcome is poor with mortality rates of 30-70%. It is therefore imperative to treat HCMV infection before it develops into disease. The aim of this article is to describe the main strategies used to prevent HCMV infection and to… CONTINUE READING